Pediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma patients treated with neoadjuvant cisplatin and docetaxel chemoradiotherapy with plasma EBV DNA quantification

dc.contributor.authorVaran, Ali
dc.contributor.authorÖzyar, Enis
dc.contributor.authorGültekin, Melis
dc.contributor.authorÇorapcıoğlu, Funda
dc.contributor.authorKöksal, Yavuz
dc.contributor.authorAydın, Burça
dc.contributor.authorAkyüz, Canan
dc.date.accessioned2020-03-26T17:17:51Z
dc.date.available2020-03-26T17:17:51Z
dc.date.issued2007
dc.departmentSelçuk Üniversitesien_US
dc.description.abstract[Abstract not Available]en_US
dc.identifier.endpage484en_US
dc.identifier.issn1545-5009en_US
dc.identifier.issue4en_US
dc.identifier.startpage484en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/21519
dc.identifier.volume49en_US
dc.identifier.wosWOS:000249116100325en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWILEY-LISSen_US
dc.relation.ispartofPEDIATRIC BLOOD & CANCERen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.titlePediatric and young adult (< 21) non-metastatic nasopharyngeal carcinoma patients treated with neoadjuvant cisplatin and docetaxel chemoradiotherapy with plasma EBV DNA quantificationen_US
dc.typeConference Objecten_US

Dosyalar